Works by Patel, Poulam M.

Results: 14

Low calpain-9 is associated with adverse diseasespecific survival following endocrine therapy in breast cancer.

Published in:

BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-995

By:

Davis, Jillian;
Martin, Stewart G.;
Patel, Poulam M.;
Green, Andrew R.;
Rakha, Emad A.;
Ellis, Ian O.;
Storr, Sarah J.

Publication type:

Article

Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer.

Published in:

2014

By:

Davis, Jillian;
Martin, Stewart G;
Patel, Poulam M;
Green, Andrew R;
Rakha, Emad A;
Ellis, Ian O;
Storr, Sarah J

Publication type:

Journal Article

Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 4001, doi. 10.1007/s00262-023-03534-z

By:

Wahid, Mussarat;
Pratoomthai, Benjamart;
Egbuniwe, Isioma U.;
Evans, Hannah R.;
Babaei-Jadidi, Roya;
Amartey, Jason O.;
Erdelyi, Viola;
Yacqub-Usman, Kiren;
Jackson, Andrew M.;
Morris, Jonathan C.;
Patel, Poulam M.;
Bates, David O.

Publication type:

Article

Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma.

Published in:

Cells (2073-4409), 2020, v. 9, n. 2, p. 263, doi. 10.3390/cells9020263

By:

Adhikaree, Jason;
Moreno-Vicente, Julia;
Kaur, Aanchal Preet;
Jackson, Andrew Mark;
Patel, Poulam M.

Publication type:

Article

Vestibulotoxicity Associated With Platinum-Based Chemotherapy in Survivors of Cancer: A Scoping Review.

Published in:

Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00363

By:

Prayuenyong, Pattarawadee;
Taylor, John A.;
Pearson, Stephanie E.;
Gomez, Rachel;
Patel, Poulam M.;
Hall, Deborah A.;
Kasbekar, Anand V.;
Baguley, David M.

Publication type:

Article

Identification of proteins regulated by interferon-α in resistant and sensitive malignant melanoma cell lines.

Published in:

Proteomics, 2004, v. 4, n. 12, p. 3998, doi. 10.1002/pmic.200400870

By:

Rachel A. Craven;
Anthea J. Stanley;
Sarah Hanrahan;
Nick Totty;
David P. Jackson;
Razvan Popescu;
Allen Taylor;
Jürgen Frey;
Peter J. Selby;
Poulam M. Patel;
Rosamonde E. Banks

Publication type:

Article

Novel function for the p38-MK2 signaling pathway in circulating CD1c+ (BDCA-1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL-12 whilst suppressing IL-10.

Published in:

International Journal of Cancer, 2014, v. 134, n. 3, p. 575, doi. 10.1002/ijc.28398

By:

Franks, Hester A.;
Wang, Qunwei;
Lax, Stephanie J.;
Collins, Mary K.;
Escors, David;
Patel, Poulam M.;
Jackson, Andrew M.

Publication type:

Article

Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors.

Published in:

International Journal of Cancer, 2012, v. 131, n. 10, p. 2433, doi. 10.1002/ijc.27512

By:

Sultana, Rebeka;
McNeill, Daniel R.;
Abbotts, Rachel;
Mohammed, Mohammed Z.;
Zdzienicka, Malgorzata Z.;
Qutob, Haitham;
Seedhouse, Claire;
Laughton, Charles A.;
Fischer, Peter M.;
Patel, Poulam M.;
Wilson, David M.;
Madhusudan, Srinivasan

Publication type:

Article

Tumour-mediated disruption of dendritic cell function: Inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generation.

Published in:

International Journal of Cancer, 2008, v. 123, n. 3, p. 623, doi. 10.1002/ijc.23530

By:

Jackson, Andrew Mark;
Mulcahy, Lori Ann;
Zhu, Xing Wu;
O'Donnell, Dearbhaile;
Patel, Poulam M.

Publication type:

Article

Biology of advanced uveal melanoma and next steps for clinical therapeutics.

Published in:

Pigment Cell & Melanoma Research, 2015, v. 28, n. 2, p. 135, doi. 10.1111/pcmr.12304

By:

Luke, Jason J.;
Triozzi, Pierre L.;
McKenna, Kyle C.;
Van Meir, Erwin G.;
Gershenwald, Jeffrey E.;
Bastian, Boris C.;
Gutkind, J. Silvio;
Bowcock, Anne M.;
Streicher, Howard Z.;
Patel, Poulam M.;
Sato, Takami;
Sossman, Jeffery A.;
Sznol, Mario;
Welch, Jack;
Thurin, Magdalena;
Selig, Sara;
Flaherty, Keith T.;
Carvajal, Richard D.

Publication type:

Article

Novel approach for interleukin-23 up-regulation in human dendritic cells and the impact on T helper type 17 generation.

Published in:

Immunology, 2011, v. 134, n. 1, p. 60, doi. 10.1111/j.1365-2567.2011.03467.x

By:

Wang, Qunwei;
Franks, Hester A.;
Porte, Joanne;
El Refaee, Mohamed;
Shah, Suharsh;
Crooks, James;
Patel, Poulam M.;
Jackson, Andrew M.

Publication type:

Article

Renal carcinoma cell lines inhibit natural killer activity via the CD94 receptor molecule.

Published in:

Cancer Immunology, Immunotherapy, 2001, v. 50, n. 5, p. 260, doi. 10.1007/s002620100194

By:

Stanley, Anthea J.;
Gough, Michael J.;
Banks, Rosamonde E.;
Selby, Peter J.;
Patel, Poulam M.

Publication type:

Article

Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.

Published in:

International Journal of Cancer, 2005, v. 115, n. 1, p. 155, doi. 10.1002/ijc.20816

By:

Ferguson, Roisean E.;
Jackson, Sharon M.;
Stanley, Anthea J.;
Joyce, Adrian D.;
Harnden, Patricia;
Morrison, Ewan E.;
Patel, Poulam M.;
Phillips, Roger M.;
Selby, Peter J.;
Banks, Rosamonde E.

Publication type:

Article

Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapy.

Published in:

International Journal of Cancer, 2004, v. 112, n. 4, p. 653, doi. 10.1002/ijc.20442

By:

Young, Sarah L.;
Murphy, Michael;
Zhu, Xing Wu;
Harnden, Patricia;
O'Donnell, Michael A.;
James, Keith;
Patel, Poulam M.;
Selby, Peter J.;
Jackson, Andrew M.

Publication type:

Article